当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第14期
编号:186092
IL-17和IL-35与多种疾病之间的研究进展
http://www.100md.com 2021年7月5日 中国医学创新 2021年第14期
     王宇航 王为光 赵悦荣 杜美霖

    【摘要】 白细胞介素17(interleukin 17,IL-17)是由辅助性T细胞17(helper T cell 17,Th17)分泌具有细胞因子性质的蛋白,白细胞介素35(interleukin 35,IL-35)是IL-12家族的新成员可抑制Th17的分化及IL-17的分泌,从而发挥免疫抑制作用。目前研究认为,IL-17和IL-35参与人类各系统疾病的发生、发展,并将与各类疾病的关系进行综述。

    【关键词】 白细胞介素17 白细胞介素35 自身免疫 肿瘤

    Research Progress between IL-17 and IL-35 and Various Diseases/WANG Yuhang, WANG Weiguang, ZHAO Yuerong, DU Meilin. //Medical Innovation of China, 2021, 18(14): -184

    [Abstract] Interleukin 17 (IL-17) is a protein with cytokine properties secreted by T helper cell (Th17), interleukin 35 (IL-35) is a new member of the IL-12 family and can inhibit the differentiation of Th17 and the secretion of IL-17, thereby exerting an immunosuppressive effect. Current research believes that IL-17 and IL-35 are involved in the occurrence and development of various human diseases, and the relationship with various diseases will be reviewed.

    [Key words] Interleukin 17 Interleukin 35 Self-immune Tumor

    First-authors address: The First Affiliated Hospital of Jiamusi University, Jiamusi 154000, China

    doi:10.3969/j.issn.1674-4985.2021.14.043 ......

您现在查看是摘要页,全文长 16550 字符